Nephrocare Health Services Ltd

Stage 2 · Advancing · week 2Setup 2.4 WatchEven +0.8

As of 16 Oct 2026, Nephrocare Health Services is in Stage 2 — advancing, the uptrend phase, in week 2 (since 8 Oct 2026). It closed at ₹614, above its 200-day average. In Health Care, 40.0% of stocks are in Stage 2.

Nephrocare Health Services Limited operates a chain of kidney care clinics that provides dialysis healthcare services with dialysis centres in India, Uzbekistan, Nepal, Kingdom of Saudi Arabia, and the Philippines. More about the company

₹614.4
+0.44% today
₹6,178 Cr · Mid cap
Market Neutral — FadingHealth Care 40.0% in Stage 2-7.4 pts / 20dHospitals & Diagnostic Centres 19.4%-19.4 pts

Pro read

Pro

Our read

In Stage 2, but it has already run

Setup score

2.4 Watch

Momentum

Steady

Edge

Even +0.8

Setup-score rank among Stage 2 peers: #6 of 6 in Hospitals & Diagnostic Centres · #67 of 70 in Health Care

Is NEPHROPLUS early, or has it already run? Pro answers that for every NSE stock, after every close.

₹2,999 · 12 months₹1,999 · 6 months
Loading price chart…
vs 52W High
—
How far this stock is from its 52-week high. A pullback of 3–20% while Stage 2 structure holds is typically a better entry than chasing near the high.
Stage Maturity
Week 2
1w13w26w
Week 2 — fresh breakout, verify structure
How long this stock has been in Stage 2. The sweet spot is mid-run — enough time to prove the structure holds, not so long it's extended. Very fresh (wk 1–4) often needs more time to confirm.
vs 200 DMA
0.5%
200 DMA: ₹611.4
Long-term trend anchor. When stock and Nifty are both above their 200 DMA, the macro backdrop supports continuation.
Rel Volume
0.34x
vs 50-day avg
Low vol (0.5–1x) on pullbacks = resting, not being sold. High vol on breakouts = commitment. Volume spike on down days is a warning sign.
Trend Health
↓
MA20 rolling over · -7.5% vs MA50 -0.1%
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
1M
-16.4%
3M
-3.4%
6M
+8.3%
YTD
+32.0%
1Y
—
Sector
Health Care
↓ Peaking
Stage 2%
40.0%
20d Δ
-7.4pp
1M return
-3.8%
3M return
-1.0%
Sector Stage-2 % · last 20 days
Industry
Hospitals & Diagnostic Centres
↓ Peaking
Stage 2%
19.4%
20d Δ
-19.4pp
1M return
-10.4%
3M return
-12.2%
Industry Stage-2 % · last 20 days
Stage Cycle Timeline2025-12-17 → 2026-10-16
S? 42w
2025-12-172026-10-16
S1S2S3S4Setup score (0–10, dashed line at 5)
S? 42w → S2 1w current
Total tracked: 43 weeks across 2 stage runs.
Scan Membership
Breakout Watch
Latest: 2026-10-08
Stocks that stay in the scan for 13+ weeks are in the highest observed-return cohort — they keep qualifying because the structure remains intact, not by luck. Persistence in the scan is itself a quality signal.
Recent Stage Timeline
2026-10-16S2
Wk 2 · Vol 0.34x
2026-10-15S2
Wk 2 · Vol 0.40x
2026-10-14S2
Wk 1 · Vol 0.34x
2026-10-13S2
Wk 1 · Vol 0.63x
2026-10-12S2
Wk 1 · Vol 0.51x
2026-10-09S2
Wk 1 · Vol 0.58x
2026-10-08S2
Wk 1 · Vol 0.45x
2026-10-07S—
Wk 41 · Vol 0.24x
2026-10-06S—
Wk 41 · Vol 1.13x
2026-10-05S—
Wk 41 · Vol 0.34x
2026-10-01S—
Wk 41 · Vol 0.60x
2026-09-30S—
Wk 41 · Vol 1.00x
Sector Peers — Stage 2All →
BAFNAPH
wk 19 · 0.0% from hi
8.6
KILITCH
wk 3 · -11.6% from hi
8.4
LAURUSLABS
wk 26 · -0.4% from hi
7.8
KOPRAN
wk 20 · -6.8% from hi
7.4
ZIMLAB
wk 23 · -5.2% from hi
6.9
Moving averages & range
50 DMA
₹688.2
200 DMA
₹611.4
52W High
—
52W Low
—
5D Low
₹611.7
Resistance levels (recent highs)
20d High
₹751.5
60d High
₹765.4
120d High
₹765.4
250d High
—
Next resistance
+22.3%
to 20d High
Ask the Market AI about NEPHROPLUSAsk →
P/E (TTM)
75.0
Forward 29.9
Earnings Growth (YoY)
+0.3%
Revenue +21.2%
ROE
+9.0%
Profit margin +7.7%
About this companyHealth Care· Hospitals & Diagnostic Centres

Nephrocare Health Services Limited operates a chain of kidney care clinics that provides dialysis healthcare services with dialysis centres in India, Uzbekistan, Nepal, Kingdom of Saudi Arabia, and the Philippines. It provides In-clinic dialysis, dialysis on call, home hemodialysis, holiday dialysis, and dialysis on wheels services. Nephrocare Health Services Limited was incorporated in 2009 and is based in Hyderabad, India.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-16. Past data patterns are not indicative of future results. This page is a data analytics tool only.